Aims-To determine whether neutrophil elastase and cathepsin G are expressed, at transcriptional or translational levels, in the bone marrow from a patient with Chediak-Higashi syndrome. Methods-Blood neutrophils were isolated from three patients with Chediak-Higashi disease and bone marrow was collected from one. Cell lysates were analysed for neutrophil elastase and cathepsin G activity by enzyme linked immunosorbent assay and western immunoblotting. Northern blotting was used to detect messenger RNA (mRNA) for cathepsin G, elastase and ,-actin in bone marrow extracts, and immunohistochemistry was used to localise the enzymes in marrow myeloid cells. Results-Elastase and cathepsin G were not detected in blood neutrophils from the patients with Chediak-Higashi disease, but were present in bone marrow cells, although immunohistochemistry showed they were not within cytoplasmic granules. The concentrations of elastase and cathepsin G in Chediak-Higashi bone marrow were about 25 and 15%, respectively, of those in normal marrow. Quantitative scanning of northern blots showed that elastase and cathepsin G mRNA, corrected for ,-actin mRNA, were expressed equally in normal marrow. Conclusions-Transcription of elastase and cathepsin G mRNA in promyelocytes of patients with Chediak-Higashi disease is normal, but the protein products are deficient in these cells and absent in mature neutrophils. This suggests that the translated proteins are not packaged into azurophil granules but are degaded or secreted from the cells. ( Clin Pathol: Mol Pathol 1995;48:M28-M34) 
Chediak-Higashi syndrome is an autosomal recessive disorder characterised by abnormal cytoplasmic granules in a variety of cells.' A major sequela of Chediak-Higashi syndrome is recurrent infection, which is thought to result from inefficient microbial killing by leucocytes, despite normal phagocytic activity and a normal respiratory burst. 2 This defect therefore appears to be associated with a deficiency in killing of bacteria by microbicidal proteins in phagolysosomes. Blood neutrophils of patients with Chediak-Higashi syndrome are deficient in the azurophil granule enzymes cathepsin G and elastase. Myeloperoxidase and the defensins, however, are present in normal or slightly reduced amounts,3 4 myeloperoxidase having been localised to the granules of the cells. 5 Cathepsin G and elastase are also deficient in blood neutrophils of the Chediak-Higashi animal model, the beige mouse. 6 The bone marrow of the beige mouse, however, contains about half the elastase and cathepsin G content of normal mouse marrow, within neutrophil precursors but not mature cells. 7 These results suggest that in this animal model the cathepsin G and elastase genes are transcribed and protein translation does occur, but the enzymes do not survive to the stage of mature cells. It is not known whether a similar situation exists in human Chediak-Higashi disease, or indeed whether transcription of these proteins is normal. The purpose of the present study was to analyse the messenger RNA (mRNA) and protein content of cathepsin G and elastase in the bone marrow of patients with ChediakHigashi syndrome.
Methods
Three patients with Chediak-Higashi syndrome were studied. Diagnosis was based on a history of recurrent infection, depigmented areas of skin, hair or retina, and characteristic giant granules in leucocytes. None had evidence of neuropathy.
Patient JF is a 25 year old man who was diagnosed when aged 13 years. He has suffered from recurrent gingivitis, eventually requiring extraction of all his teeth, and multiple skin infections which have been treated with antibiotics and occasional surgical drainage. He has had no major chest or urinary tract infections.
Patient GH is a 10 year old boy, diagnosed when five years old. He has had a history of frequent respiratory tract and throat infections, oral ulceration, paronychia, and skin bruising following minor trauma. Relatively minor abrasions to the skin were delayed in healing and often became septic.
Patient AE is a four year old girl with a history of recurrent infections of the urinary tract, respiratory tract and throat from the age of six weeks. She has recently suffered from mouth ulcers and paronychia.
Blood neutrophils were purified as described healthy volunteer, into lithium heparin anticoagulant and each blood sample was diluted with an equal volume of 0 15 mol/l NaCl solution. The diluted blood (5 ml) was layered onto two layers of Percoll (Pharmacia AB, Uppsala, Sweden); the upper layer was 2 ml 1-075 g/ml Percoll, the lower 3 ml 1-096 g/ml Percoll. The tubes were centrifuged at 2000 x g for 20 minutes. The neutrophils were harvested from the interface between the Percoll layers, washed three times in TRIS buffered RPMI 1640 medium (Flow Laboratories, Rickmansworth, UK), counted and resuspended in RPMI 1640 medium. The polymorphonuclear leucocytes (PMN) were >96% pure and >98% viable (assessed by exclusion of trypan blue). The neutrophil preparations from each subject were separated into two samples, centrifuged and the cell pellets retained. One sample from each subject (for enzyme activity assays) was lysed by the addition of 0 5 M Tris/HCl, pH 7-8, containing 1-0M NaCl and 0-1% (v/v) Triton X-100 and sonicated (6 x 20 W) using a Lucas Dawe Ultrasonics Soniprobe. The second sample (for western immunoblotting and enzyme linked immunosorbent assay (ELISA)) was lysed by sonication with 0 5 M Tris/HCl, pH 7-8 containing 1 0 M NaCl and 0 1% (v/v) Triton X-100, after the addition of proteinase inhibitors; 25 5 ,ul 100 mM diisopropyl fluorophosphate dissolved in dimethyl sulphoxide, 0 1 ml 0 1 M 1,10 phenanthroline in methanol and 0-1 ml 0-1 M iodoacetic acid in water. Northem blotting was performed essentially as described by Maniatis et al. ' 3 The mRNA preparations (about 10,ug) from normal and Chediak-Higashi bone marrow samples, suspended in denaturing buffer (MOPS containing formamide and formaldehyde), were subjected to electrophoresis in 1% (w/v) agarose gels in 0-2 M MOPS buffer (pH 7-0) containing 2-2 M formaldehyde, 50 mM sodium acetate and 1 mM EDTA. Following electrophoresis, the RNA samples were transferred by capillary blotting to Genescreen TM (NEN Research, Boston, USA). The Genescreen was prehybridised for 12 hours at 42°C before the addition ofthe cathepsin G probe or the elastase probe (106 ng), radiolabelled with ["P] dCTP to 109 dpm/mg DNA using a commercial random prime labelling kit (Boehringer Mannheim, Lewes, UK). Hybridisation took place for 18 hours at 42°C in the presence of 50% formamide. The screens were then washed four times with 2 x standard sodium citrate (SSC) at 20°C and twice with 0-2 x SSC at 65°C
(1 x SSC = 0 15MNaCl,0-015Msodium citrate, pH 7*0). The screens were autoradiographed at -70°C and that which had been probed with the elastase cDNA was scanned with LKB Wallach 1205 [ plate flat bed counter in the scintillation mode. When the radioactivity of the elastase probed screen had decayed to undetectable levels, it was reprobed with radiolabelled [3-actin cDNA, autoradiographed and scanned again. The ratios of radioactivity caused by hybridisation of elastase mRNA and P-actin mRNA in normal and Chediak-Higashi bone marrow samples were calculated from the scans.
Neutrophil and bone marrow lysates were subjected to sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE), as described by Laemmli,'4 on an LKB "Midget" system (Pharmacia LKB Biotechnology, Milton Keynes, UK) using a 5% polyacrylamide stacking gel and 12-5% running gel. Each sample loaded contained lysate from 104 cells. Following electrophoresis, the proteins were transferred to nitrocellulose paper (Hybond-C; Amersham International) by electroblotting. The nitrocellulose sheets were incubated with either sheep antineutrophil elastase'5 or sheep anticathepsin G,'6 followed by donkey antisheep IgG labelled with horseradish peroxidase (Binding Site, Birmingham, UK). Binding of peroxidase labelled antibody was visualised using 3-amino-9-ethylcarbazole as the substrate.
Cathepsin G was measured in blood neutrophil and bone marrow lysates using a direct capture ELISA. Nunc Immuno 96 well plates were loaded with 0-2 ml sheep antihuman cathepsin G, 20 jtl/ml in phosphate buffered saline (PBS) (pH 7 2) and incubated overnight at 4°C. The wells were washed three times with washing buffer (PBS containing 0-1% Tween- 20 and 1% (v/v) Haemaccel (Hoechst)) before the addition of 0-2 ml of each cell lysate diluted in washing buffer with 0 5 M NaCl. Reference standards consisted of dilutions of cathepsin G, purified from an empyema as described by Martodam et al. 7 The plates were incubated for two hours at room temperature before washing, followed by the addition of a horseradish peroxidase conjugated sheep anticathepsin G. After a further two hours of incubation, the wells were washed and substrate added; 0-2 ml/well 1 mg/ml o-phenylenediamine dihydrochloride (Sigma) in 0 1 M citrate/phosphate buffer (pH 5 0) with 1 ,ul/ml hydrogen peroxide. The colour reaction was stopped with 50 gil 0-5 M citric acid/well and the absorbance measured with a Dynatech MR 5000 plate reader at 490 nm. Cathepsin G concentrations in the cell lysates were calculated by interpolation from the reference values obtained with pure enzyme. The lower limit of detection was 3 ng/ml.
Neutrophil elastase in cell lysates was measured using an indirect competition ELISA. Nunc Immuno 96 well plates were loaded with 0-2 ml elastase, 1 ,ug/ml in PBS, pH 7-2, with 0-5 M NaCl and incubated overnight at 4°C. The cell lysates and dilutions of elastase, purified from an empyema,17 were each mixed with equal volumes of 25 jg/ml sheep antielastase, which were also incubated overnight at 4°C. The ELISA plates were washed and the lysates and reference mixtures (0.2 ml/well) added and incubated for two hours at room temperature. After further washing, the plate wells were loaded with 0-2 ml horseradish peroxidase conjugated donkey antisheep IgG (Binding Site) and incubated for two hours at room temperature, before the addition of substrate solution and measurement of the absorbance at 490 nm, as described earlier. The elastase concentrations in the cell lysates were calculated by interpolation from the inhibition binding reference line obtained with pure elastase, the lower limit of detection being 3 ng/ml. Results for both enzymes were expressed as pg protein/ myeloid cell.
Cathepsin G and elastase activities in blood neutrophil and bone marrow lysates were measured in microtitre plate wells using fluorimetric substrates, Succ-Ala-Ala-Pro-Phe-paranitroanilide and Succ-Ala-Ala-Ala-paranitroanilide, respectively (Bachem Feinchemikalien, Bubendorf, Switzerland). Samples (40 p1) of the cell lystates and dilutions of calibration standards of pure cathepsin G or elastase were mixed with 140 jil substrate buffer (0 05 mol/l TRIS/ HCI buffer containing 0 5 mol/l NaCl and 1%
(v/v) Triton X-1 00 and 1 mg/ml of the appropriate substrate). The plates were incubated at room temperature until colour change was sufficient and the absorbance of each well was measured at 410 nm with a Dynatech MR 5000 plate reader. Cathepsin G and elastase concentrations in cell lysates were calculated by interpolation from the calibration curves obtained with pure enzymes. The lower limits of detection for cathepsin G and elastase activity were 190 and 150 ng/ml, respectively. Results were expressed as activity representing pg enzyme/myeloid cell.
The cytocentrifuge preparations from the bone marrow samples were stained immunohistochemically for cathepsin G and elastase as described previously.'5 16 . ates contained similar amounts of the elastase mRNA transcript relative to that of f-actin.
WESTERN IMMUNOBLOTTING
Cathepsin G and elastase were not detected in the lysates from blood neutrophils isolated from any of the three Chediak-Higashi patients, whereas both proteins (molecular weight about 29 500) were evident in the normal neutrophils (fig 2) . Figure 3 shows the results of western blotting using lysates from the bone marrow samples. Figure 4 shows the results of immunohistochemical staining of bone marrow, from the Chediak-Higashi patient and a normal donor, for cathepsin G. In the normal marrow cathepsin G could be seen within the granules of the cells, whereas the Chediak-Higashi promyelocyte granules showed no staining.
Discussion
In the present study we have confirmed the observation of Ganz et al' that elastase and cathepsin G are undetectable in mature blood neutrophils from patients with ChediakHigashi disease. The fundamental cause ofneutrophil cathepsin G and elastase deficiency in Chediak-Higashi syndrome has not, however, been established. Elastase, coded for on chromosome 19pter'8 and cathepsin G, on chromosome 1lq14 2,1" are both transcribed, synthesised and packaged within the promyelocyte during myeloid differentiation in the bone marrow,"' 1920 when the azurophil granules are formed21; transcription and synthesis cease before the cells become mature neutrophils. Both enzymes are translated as pre-pro-proteins and thence processed via enzymatically inactive pro-proteins to the mature active enzymes. 22 Activation from the pro-enzyme appears to involve the proteolytic removal of an acidic N terminal dipeptide, Ser-Glu in the case of elastase and Gly-Glu for cathepsin G, and C terminal extensions of 20 and 11 amino acids in elastase and cathepsin G, respectively. The N terminal sequences of the mature proteins share considerable homology, suggesting common dipeptidyl peptidases are responsible for processing the pro-proteins.22 The C terminal extensions of the pro-proteins are not homologous. The mechanisms determining packaging to the azurophil granules are not known. The deficiency of these enzymes in Chediak-Higashi syndrome could potentially occur at any of these several stages of processing. The identification of the mature enzymes within bone marrow promyelocytes of the beige mouse suggested, however, that transcription of the genes for these enzymes and translation of the proteins do occur. Thus, the deficiency would be a consequence of posttranslational events.
In the present study we have shown that in bone marrow from a patient with ChediakHigashi syndrome the levels of the mRNA transcripts for cathepsin G and elastase, when corrected for ,B-actin mRNA levels, were similar to those of normal marrow. Thus, if 1-actin transcription is normal in Chediak-Higashi myeloid cells the results would suggest that transcription both of cathepsin G and elastase is also normal.
The bone marrow myeloid cells of the patients with Chediak-Higashi syndrome contained mature, active elastase and cathepsin G. As in the beige mouse, the concentrations of these enzymes were lower than those of marrow from a normal subject and undetectable in mature blood neutrophils. The ChediakHigashi marrow protein concentrations were only about one fifth of those seen in normal marrow. This is less than the value for the beige mouse marrow, which was reported to be about 60% of normal. 6 Enzyme activity measurements in marrow samples were slightly lower than the protein concentrations estimated using ELISA. This difference may represent a technical discrepancy. Alternatively, it is possible that some inactive, unprocessed, pro-elastase and procathepsin G were present within the marrow cells, although there was no evidence for this on the western blots. The western blots of elastase and cathepsin G from ChediakHigashi bone marrow samples showed, in addition to molecular weight bands consistent with the mature proteins, smaller forms which were not observed in lysates of normal marrow or of blood neutrophils. These small forms could represent differences in glycosylation. Alternatively, they might represent proteolysed forms although proteinase inhibitors were added to the marrow and neutrophils before lysis to prevent proteolytic modification of proteins during the processing of samples for blotting. The presence of the "smaller" form of elastase and cathepsin G in Chediak-Higashi marrow suggests, therefore, that some proteolytic degradation may have occurred before sampling-that is, in vivo. This has relevance to the possible fate of these proteins in Chediak-Higashi marrow, but further studies would be necessary to establish the reasons for this observation. Nevertheless, the presence of active elastase and cathepsin G in the myeloid cells of the Chediak-Higashi marrow shows that these proteins had been synthesised and processed to mature, active enzymes. This indicates that a deficiency in proteinases involved in processing of the pro-enzymes is not responsible for the absence of elastase and cathepsin G in Chediak-Higashi neutrophils.
Takeuchi and Swank23 characterised inhibitors of elastase and cathepsin G, which formed covalent complexes with the enzymes, in mature neutrophils of beige mice; these inhibitors were absent from normal mouse cells and beige mouse pro-myelocytes. It was suggested that the absence of elastase and cathepsin G activities in beige mouse 
